Key facts
- It has raised $690K; the latest was Seed Round ($690K) in Jun 2025.
- Notable investors include Scientifica.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Loto Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Loto Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Loto Biotech
Operator of a biotechnology company intended to facilitate scalability, reduce operational burden, and enable cost-efficient expansion across therapeutic areas. The company specializes in the development of siRNA molecules capable of selectively "silencing" mutated genes responsible for serious, rare genetic diseases, enabling clients to deliver impact where it matters most, that is, to patients in need.
- Sector
- Healthcare
- HQ
- Pescara, Italy
- Founded
- 2025
- Website
- lotobiotech.com/
- Ownership
- Privately Held (backing)
Loto Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Loto Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Loto Biotech in its N-PORT filings yet. We sweep new filings monthly.